Innovation Pharmaceuticals Inc (IPIX)

[georgejjl]

Does anyone here know the answer to this question

There was only one serious adverse event reported in the last Prurisol trial.

...Regarding Prurisol’s safety profile, only a single Serious Adverse Event (SAE) was reported in the study, that being in the 50mg arm, with the type and the rate of occurrence of additional Adverse Events (AEs) similar and evenly distributed across all the three dosing arms and the placebo arm....

- See more at: http://cellceutix.com/cellceutix-phase-2-trial-of-prurisol-for-mild-to-moderate-psoriasis-meets-primary-endpoint/#sthash.2h2hYLV3.dpuf

My question is whether the patient who experienced the single adverse event might have had the human leukocyte antigen subtype B*5701 (HLA-B*5701) allele???

Good luck and GOD bless,

George